Huang W, Czuba L, Isoherranen N
J Pharmacol Exp Ther. 2020; 373(3):488-501.
PMID: 32198137
PMC: 7250368.
DOI: 10.1124/jpet.120.264994.
Fukao M, Kondo E, Nishino H, Hattori R, Horie A, Hashimoto Y
Eur J Drug Metab Pharmacokinet. 2015; 41(6):819-824.
PMID: 26628429
DOI: 10.1007/s13318-015-0314-1.
Ogawa R, Echizen H
Drugs. 2011; 71(14):1839-64.
PMID: 21942976
DOI: 10.2165/11593990-000000000-00000.
Jurgens G, Graudal N, Kampmann J
Clin Pharmacokinet. 2003; 42(7):647-63.
PMID: 12844326
DOI: 10.2165/00003088-200342070-00004.
Trujillo T, Nolan P
Drug Saf. 2001; 23(6):509-32.
PMID: 11144659
DOI: 10.2165/00002018-200023060-00003.
Therapeutic drug monitoring: antiarrhythmic drugs.
Campbell T, Williams K
Br J Clin Pharmacol. 1998; 46(4):307-19.
PMID: 9803978
PMC: 1874159.
DOI: 10.1046/j.1365-2125.1998.t01-1-00768.x.
Drug interactions with antacids. Mechanisms and clinical significance.
Sadowski D
Drug Saf. 1994; 11(6):395-407.
PMID: 7727050
DOI: 10.2165/00002018-199411060-00002.
The pharmacological role of the kidney.
Brater D
Drugs. 1980; 19(1):31-48.
PMID: 6988197
DOI: 10.2165/00003495-198019010-00003.
Urinary excretion kinetics of intact quinidine and 3-OH-quinidine after oral administration of a single oral dose of quinidine gluconate in the fasting and non-fasting state.
Sirois G, Gagnon M
Eur J Drug Metab Pharmacokinet. 1983; 8(4):363-72.
PMID: 6673973
DOI: 10.1007/BF03188768.
Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
Rakhit A, Guentert T, Holford N, Verhoeven J, RIEGELMAN S
Eur J Drug Metab Pharmacokinet. 1984; 9(4):315-24.
PMID: 6532805
DOI: 10.1007/BF03189683.
Alkalinization therapy for tricyclic antidepressant overdose.
West J Med. 1981; 134(5):450-2.
PMID: 6266163
PMC: 1272788.
Bicarbonate therapy for dysrhythmia and hypotension in tricyclic antidepressant overdose.
Hoffman J, McElroy C
West J Med. 1981; 134(1):60-4.
PMID: 6259839
PMC: 1272464.
Quinidine overdose. Neurological and cardiovascular toxicity in a normal person.
Kerr F, Kenoyer G, Bilitch M
Br Heart J. 1971; 33(4):629-31.
PMID: 5557506
PMC: 487225.
DOI: 10.1136/hrt.33.4.629.
Serum quinidine levels after administration of three different quinidine preparations.
Henning R, Nyberg G
Eur J Clin Pharmacol. 1973; 6(4):239-44.
PMID: 4591150
DOI: 10.1007/BF00644739.
Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
Kim S, Benowitz N
Drug Saf. 1990; 5(6):393-420.
PMID: 2285495
DOI: 10.2165/00002018-199005060-00002.
Dose-dependence of the pharmacokinetics of quinidine.
Bolme P, Otto U
Eur J Clin Pharmacol. 1977; 12(1):73-6.
PMID: 902678
DOI: 10.1007/BF00561409.
Drug interactions and clinical pharmacokinetics.
Kristensen M
Clin Pharmacokinet. 1976; 1(5):351-72.
PMID: 797504
DOI: 10.2165/00003088-197601050-00003.
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Anderson J, Harrison D, Meffin P, Winkle R
Drugs. 1978; 15(4):271-309.
PMID: 648399
DOI: 10.2165/00003495-197815040-00003.
Antacid therapy and drug kinetics.
Hurwitz A
Clin Pharmacokinet. 1977; 2(4):269-80.
PMID: 332427
DOI: 10.2165/00003088-197702040-00003.
Editorial: How innocuous is the white medicine?.
Br Med J. 1975; 2(5968):405-6.
PMID: 236063
PMC: 1681834.
DOI: 10.1136/bmj.2.5968.405.
